Alexander Marx Selected Research

Thymoma (Thymic Carcinoma)

4/2022	POU2F3 beyond thymic carcinomas: expression across the spectrum of thymomas hints to medullary differentiation in type A thymoma.
1/2022	The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
10/2021	Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC study.
1/2021	Molecular pathology of thymomas: implications for diagnosis and therapy.
2/2020	Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma.
2/2019	Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravis.
1/2019	Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1.
12/2018	The Integrated Genomic Landscape of Thymic Epithelial Tumors.
10/2017	Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling.
4/2017	Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Marx Research Topics

Disease

62	Neoplasms (Cancer) 01/2022 - 01/2002
37	Thymoma (Thymic Carcinoma) 04/2022 - 07/2002
23	Myasthenia Gravis 02/2019 - 07/2002
15	Neoplasm Metastasis (Metastasis) 07/2021 - 05/2007
8	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 10/2016
7	Rhabdomyosarcoma 01/2018 - 01/2006
7	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 09/2007
4	Thymus Neoplasms (Thymus Neoplasm) 09/2021 - 10/2010
4	Carcinoma (Carcinomatosis) 07/2021 - 02/2016
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2009
4	Inflammation (Inflammations) 01/2018 - 01/2008
4	Chorioamnionitis 04/2009 - 02/2005
3	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 05/2007
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2021 - 05/2007
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2013
3	Infections 02/2019 - 01/2008
3	Adenocarcinoma 10/2018 - 08/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2022
2	Microsatellite Instability 12/2021 - 01/2019
2	Hyperplasia 10/2021 - 12/2012
2	Carcinogenesis 01/2021 - 08/2011
2	Autoimmune Diseases (Autoimmune Disease) 12/2018 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2014 - 01/2003
2	Disease Progression 01/2014 - 01/2002
2	Hepatocellular Carcinoma (Hepatoma) 10/2013 - 03/2013
2	Lymphoma (Lymphomas) 03/2013 - 09/2005
2	Atherosclerosis 10/2009 - 07/2006
1	COVID-19 09/2022
1	Endocrine Gland Neoplasms (Cancer, Endocrine) 03/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Teratoma (Teratoid Tumor) 01/2022
1	Acute-On-Chronic Liver Failure 01/2022

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2007
20	Cholinergic ReceptorsIBA 01/2019 - 03/2005
12	AutoantibodiesIBA 02/2019 - 01/2006
8	Biomarkers (Surrogate Marker)IBA 07/2021 - 08/2013
7	Messenger RNA (mRNA)IBA 01/2021 - 09/2008
6	AntibodiesIBA 10/2021 - 03/2005
5	Imatinib Mesylate (Gleevec)FDA Link 02/2021 - 06/2004
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
5	Prednisone (Sone)FDA LinkGeneric 01/2019 - 12/2012
5	Phosphotransferases (Kinase)IBA 01/2016 - 03/2005
4	AntigensIBA 08/2020 - 09/2008
4	CytokinesIBA 01/2020 - 07/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 09/2005
4	margatoxinIBA 01/2019 - 12/2012
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2010 - 01/2008
3	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2017
3	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2018
3	Insulin-Like PeptidesIBA 01/2018 - 09/2007
3	ParaffinIBA 12/2014 - 01/2009
3	Urokinase Plasminogen Activator ReceptorsIBA 05/2010 - 01/2009
3	Ribonucleases (Ribonuclease)IBA 09/2008 - 06/2002
2	Keratins (Keratin)IBA 01/2022 - 09/2014
2	Biological ProductsIBA 01/2022 - 12/2018
2	LigandsIBA 01/2022 - 05/2016
2	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2014
2	Monoclonal AntibodiesIBA 01/2020 - 10/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 05/2014
2	CateninsIBA 01/2019 - 01/2018
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 05/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2014
2	Indicators and Reagents (Reagents)IBA 10/2017 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2017 - 01/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2017 - 09/2005
2	SteroidsIBA 12/2015 - 01/2011
2	PlakophilinsIBA 12/2015 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 05/2007
2	Sunitinib (Sutent)FDA Link 02/2015 - 10/2010
2	muskIBA 01/2015 - 03/2005
2	RNA (Ribonucleic Acid)IBA 01/2015 - 06/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 02/2005
2	Formaldehyde (Formol)FDA Link 12/2014 - 01/2009
2	SurvivinIBA 01/2014 - 06/2013
2	Sorafenib (BAY 43-9006)FDA Link 10/2013 - 10/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2012 - 01/2008
2	ChemokinesIBA 08/2011 - 09/2005
2	Serine Proteases (Serine Protease)IBA 05/2010 - 06/2009
2	Apolipoproteins E (ApoE)IBA 10/2009 - 07/2006
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2009 - 05/2007
2	Protein Isoforms (Isoforms)IBA 09/2007 - 06/2002
2	Immunoglobulins (Immunoglobulin)IBA 09/2005 - 11/2004
1	Biocompatible Materials (Biomaterials)IBA 09/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 04/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2022
1	eltrombopag FDA Link 01/2022
1	FollistatinIBA 01/2022

Therapy/Procedure

26	Therapeutics 01/2022 - 07/2002
10	Drug Therapy (Chemotherapy) 07/2021 - 07/2002
8	Thymectomy 02/2019 - 03/2003
6	Immunotherapy 01/2019 - 02/2013
3	Lasers (Laser) 01/2019 - 01/2009
2	Neoadjuvant Therapy 01/2016 - 01/2014
2	Adjuvant Radiotherapy 12/2012 - 04/2004
2	Radiotherapy 09/2009 - 01/2004
2	Aftercare (After-Treatment) 09/2009 - 08/2003
2	Adjuvant Chemoradiotherapy 04/2004 - 07/2002
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Ambulatory Care (Outpatient Care) 11/2021